The optimal level of serum vitamin D is unknown but is usually determined according to PTH levels. Professional societies defi ne vitamin D defi ciency when the level of 25-hydroxyvitamin D 3 is below 10 -20 ng/ml and insuffi ciency when the level of 25-hydroxyvitamin D 3 is between 10 -20 and 30 ng/ml (17 -19). Vitamin D intoxication is observed when serum levels of 25-hydroxyvitamin D 3 are greater than 150 ng/ml.
Introduction
There has recently been growing interest in the role of vitamin D in neurological disorders, including ALS (1 -9). Physicians on internet blogs (10) and in chat rooms (11) have even begun suggesting that PALS (PALS) take vitamin D. In this paper, on behalf of patients with ALS (PALS) who are asking about it (11), we review vitamin D in general, and its potential role in ALS.
What is vitamin D and what are its general roles in health and disease?
Vitamin D is a fat-soluble secosteroid. Vitamin D can be found in certain foods but the main source is from the sun. The skin can synthesize vitamin D3 (cholecalciferol) through ultraviolet irradiation of 7-dehydrocholesterol. Vitamin D3 must then be metabolized to 25-hydroxyvitamin D 3 in the liver and then to 1 α ,25-dihydroxyvitamin D 3 in the kidney before function (12). Because the human body produces its own vitamin D, the concept that it is a vitamin is incorrect. 1 α ,25-dihydroxyvitamin D 3 binds to a single vitamin D receptor (VDR), which is a nuclear receptor. Following a reaction between 1 α ,25-dihydroxyvitamin D 3 and the VDR, DNA transcription is either initiated or suppressed, depending on the gene.
The most established function of vitamin D is to increase serum calcium concentrations (12). Hence, it is essential for skeletal mineralization, preventing rickets in children and ostemomalacia in adults and for prevention of hypocalcemic tetany (12,13). However, the role of vitamin D extends beyond calcium and the bone. Vitamin D receptors (VDRs) are widespread in the human body and not limited only to enterocytes, osteoblasts, and distal renal tubule cells (14) . Some of the proven roles of vitamin D outside of bone and calcium include: terminal differentiation of promyelocytes to monocytes, preventing proliferation of parathyroid gland cells and infl uencing T-cell mediated immunity (12 -16).
ALSUntangled Update 24 319 same group. In the fi rst, the mice were fed with either an adequate (1 IU D(3)/g feed) or defi cient (0.025 IU D(3)/g feed) dietary intake of vitamin D (2). Mice on the defi cient diet had delayed ALS onset, but worse motor performance following onset. In a second study, G93A mice were fed with either an adequate (1 IU/g feed) or high dose (10 IU/g feed) dietary intake of vitamin D (4). Mice in the high dose group had marginally better motor performance (not meeting statistical signifi cance since p Ͼ 0.05). There were no differences in ALS onset, progression rate or lifespan. In a third study, G93A mice were fed with either an adequate (1 IU D (3)/g feed) or very high dose (50 IU D(3)/g feed) dietary intake of vitamin D (5) . Mice on the very high dose had improved motor performance ( p Ͻ 0.05) but there was still no effect on ALS onset, progression or lifespan. Furthermore, female mice showed evidence of possible vitamin D(3) toxicity as evidenced by reduced food intake. These are all small studies and have not been independently replicated.
What do we know about vitamin D in PALS?
Arguing against a role for vitamin D defi ciency in causing ALS are the epidemiological observations that people born in the summer are actually slightly more likely to develop ALS, and that there is no latitudinal gradient in ALS incidence (30).
One group studied the relation between vitamin D levels and ALS progression (9). This small study of 74 ALS patients concluded that vitamin D levels were generally low in PALS, and that those patients with severely low vitamin D levels had more rapid progression of their ALSFRS-R scores and shorter survival compared to patients with normal vitamin D levels. Unfortunately, this observation may be biased; patients who are sicker might tend to stay indoors longer and hence have a lower vitamin D level.
In another even smaller study, vitamin D levels were checked in 37 consecutive PALS (6). The mean vitamin D level in the ALS group was below normal at 22.3 ng/ml (normal range, 30 -80 ng/ml), with 81% of the ALS group having a vitamin D level lower than 30 ng/ml, and 43% being lower than 20 ng/ml. Twenty PALS took 2000 IU of vitamin D daily. After adjustment for age and baseline vitamin D levels in a linear regression model, the ALSFRS-R score decline was smaller in patients taking vitamin D at nine months ( p ϭ 0.02), although not significantly different at three or six months. Median vitamin D levels rose from 18.5 to 31.0 ng/ml at six months in the group taking vitamin D. No side-effects secondary to vitamin D supplementation were reported. This study confi rms that PALS may have vitamin D defi ciency, which is common in many chronic illnesses. However, given the small numbers and limited follow-up, it is not clear from this whether supplementing vitamin D can slow ALS progression or prolong survival.
Within the PRO-ACT database (31) there are 110 patients on vitamin D and 4728 not on vitamin D who have multiple ALSFRS or ALSFRS-R scores. There is no difference in ALSFRS or ALSFRS-R progression between these two groups (Table I) . Vitamin D levels in these patients are not known. Within the PatientsLikeMe community, there are fi ve PALS who report taking vitamin D for their ALS, and two of these have publicly available evaluations. Neither patient noted any perceived benefi ts or side-effects (32). A Google search of ' vitamin D for ALS ' uncovered no additional reports of patients taking vitamin D for their ALS.
Costs and potential side-effects
Vitamin D is not expensive. A fi ve-month supply costs around $ 11 (33). However, there can be signifi cant side-effects, particularly at higher doses. The Endocrine Society ' s Upper Limit of safe levels is 10,000 IU/day (34). Beyond that dosing range there are risks for hypocalcemia, which can be life threatening. 
Conclusion

